title: Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation.
abstract: BACKGROUND
  In myeloid blasts, the expression and release of the multifunctional chemokine IL-8 could be expected to be differentiation-associated.
  
  
  METHODS
  We investigated the profile of interleukin-8 (IL-8) expression and release by leukemic cells obtained at diagnosis from 42 untreated adult patients with acute myeloid leukemia of various FAB subtypes (2 M0, 7 M1, 6 M2, 6 M3, 10 M4 and 11 M5). IL-8 transcripts were evaluated by Northern blot and densitometric analysis. IL-8 release by myeloid blasts was evaluated by a specific ELISA either in sera at diagnosis or in supernatants (SN) obtained from cultured leukemic cells.
  
  
  RESULTS
  In basal conditions, Northern blot analysis revealed detectable IL-8 transcripts in 15/29 cases, eleven of which were classified as M4-M5 and 4 as FAB M0-M3. Densitometric analysis of IL-8 transcript bands showed higher expression in M4-M5 than in M0-M3 cases (mean values +/- SD: 16.5 +/- 21 and 0.77 +/- 1.36 densitometric units, respectively; p = 0.012). Higher IL-8 serum levels were observed in leukemic patients as opposed to normal controls (mean values +/- SD: 0.53 +/- 0.75 vs 0.003 +/- 0.014 ng/mL, respectively; p = 0.006). Furthermore, a trend (though not of statistical significance) towards higher IL-8 serum values was observed in M4-M5 as opposed to M0-M3 subtypes. After 24 hours of culture, the majority of myeloid blasts (95%) spontaneously released detectable amounts of IL-8 into SN. However, M4-M5 released substantially higher amounts of IL-8 than M0-M3 blasts (mean +/- SD: 68 +/- 46 and 8.5 +/- 12 ng/mL, respectively; p < 0.001). This difference between M0-M3 and M4-M5 blasts was already observed after 6 hours of culture and increased over 72 hours.
  
  
  CONCLUSIONS
  Our findings confirm and further support the preferential release of high levels of IL-8 by myeloid blasts showing monocytic differentiation.
authors.affiliation: Department of Hematology, Verona University School of Medicine, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Vinante
authors.forename: A
authors.initials: A
authors.lastname: Rigo
authors.forename: C
authors.initials: C
authors.lastname: Tecchio
authors.forename: C
authors.initials: C
authors.lastname: Patuzzo
authors.forename: M M
authors.initials: MM
authors.lastname: Ricetti
authors.forename: L
authors.initials: L
authors.lastname: Morosato
authors.forename: M A
authors.initials: MA
authors.lastname: Cassatella
authors.forename: M
authors.initials: M
authors.lastname: Chilosi
authors.forename: G
authors.initials: G
authors.lastname: Pizzolo
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D002454:Cell Differentiation / Q000502:physiology; D006801:Humans; D016209:Interleukin-8 / Q000378:metabolism*; D007951:Leukemia, Myeloid / Q000378:metabolism* / Q000473:pathology; D008875:Middle Aged; D009000:Monocytes / Q000166:cytology*; D014407:Tumor Cells, Cultured
chemical_list: D016209:Interleukin-8